ALCHEMIA ANNOUNCES CAPITAL RAISING TO PROGRESS PROMISING NEW DRUG CANDIDATES

A A

Australian drug development company Alchemia Limited (ASX: ACL) today announced it had raised $14.6 million through an institutional and sophisticated investor share placement and would commence a share purchase plan (SPP) to offer an additional $5 million to existing shareholders to fund the progression of its promising drug discovery programs.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/39f07abd2b195a4bddcfb06ec9a20f11.html)